Dipyridamole-Associated Shock and Pulmonary Edema;Oxcarbazepine-Induced Resistant Ventricular Fibrillation;Finasteride-Induced Pseudoporphyria;Suicidal Ideation Associated with Asenapine;Rediscovering Adverse Anticholinergic Effects;Prevalence of Adverse Drug Events in Ambulatory Care

Abstract

The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), discuss methods of prevention, and promote reporting of ADRs to the US Food and Drug Administration's (FDA's) MedWatch program (800-FDA-1088). If you have reported an interesting, preventable ADR to MedWatch, please consider sharing the account with our readers.